Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Immunoglobulin G N-glycosylation signatures in incident type 2 diabetes and cardiovascular disease (CROSBI ID 315359)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Birukov, Anna ; Plavša, Branimir ; Eichelmann, Fabian ; Kuxhaus, Olga ; Hoshi, Rosangela Akemi ; Rudman, Najda ; Štambuk, Tamara ; Trbojević- Akmačić, Irena ; Schiborn, Catarina ; Morze, Jakub et al. Immunoglobulin G N-glycosylation signatures in incident type 2 diabetes and cardiovascular disease // Diabetes care, 45 (2022), 11; 2729-2736. doi: 10.2337/dc22-0833

Podaci o odgovornosti

Birukov, Anna ; Plavša, Branimir ; Eichelmann, Fabian ; Kuxhaus, Olga ; Hoshi, Rosangela Akemi ; Rudman, Najda ; Štambuk, Tamara ; Trbojević- Akmačić, Irena ; Schiborn, Catarina ; Morze, Jakub ; Mihelčić, Matea ; Cindrić, Ana ; Liu, Yanyan ; Demler, Olga ; Perola, Markus ; Mora, Samia ; Schulze, Matthias B. ; Lauc, Gordan ; Wittenbecher, Clemens

engleski

Immunoglobulin G N-glycosylation signatures in incident type 2 diabetes and cardiovascular disease

OBJECTIVE N-glycosylation is a functional posttranslational modification of immunoglobulins (Igs). We hypothesized that specific IgG N-glycans are associated with incident type 2 diabetes and cardiovascular disease (CVD). RESEARCH DESIGN AND METHODS We performed case-cohort studies within the population-based European Prospective Investigation into Cancer and Nutrition (EPIC)– Potsdam cohort (2, 127 in the type 2 diabetes subcohort [741 incident cases] ; 2, 175 in the CVD subcohort [417 myocardial infarction and stroke cases]). Relative abundances of 24 IgG N-glycan peaks (IgG-GPs) were measured by ultraperformance liquid chromatography, and eight glycosylation traits were derived based on structural similarity. End point–associated IgG-GPs were preselected with fractional polynomials, and prospective associations were estimated in confounder-adjusted Cox models. Diabetes risk associations were validated in three independent studies. RESULTS After adjustment for confounders and multiple testing correction, IgG-GP7, IgG-GP8, IgG-GP9, IgG-GP11, and IgG-GP19 were associated with type 2 diabetes risk. A score based on these IgG-GPs was associated with a higher diabetes risk in EPIC- Potsdam and independent validation studies (843 total cases, 3, 149 total non-cases, pooled estimate per SD increase 1.50 [95% CI 1.37– 1.64]). Associations of IgG-GPs with CVD risk differed between men and women. In women, IgG-GP9 was inversely associated with CVD risk (hazard ratio [HR] per SD 0.80 [95% CI 0.65–0.98]). In men, a weighted score based on IgG-GP19 and IgG- GP23 was associated with higher CVD risk (HR per SD 1.47 [95% CI 1.20–1.80]). In addition, several derived traits were associated with cardiometabolic disease incidence. CONCLUSIONS Selected IgG N-glycans are associated with cardiometabolic risk beyond classic risk factors, including clinical biomarkers.

N-glycosylation, immunoglobulin G, type 2 diabetes, CVD

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

45 (11)

2022.

2729-2736

objavljeno

0149-5992

1935-5548

10.2337/dc22-0833

Povezanost rada

Biologija, Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)

Poveznice
Indeksiranost